Total Payments
$887.37
2024 Payments
$111.61
Companies
21
Transactions
44
Payment Breakdown by Category
Food & Beverage$875.08 (98.6%)
Education$12.29 (1.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $875.08 | 43 | 98.6% |
| Education | $12.29 | 1 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme Corporation | $105.70 | 7 | $0 (2019) |
| Progenics Pharmaceuticals, Inc. | $96.03 | 1 | $0 (2022) |
| EISAI INC. | $76.36 | 4 | $0 (2019) |
| PFIZER INC. | $75.89 | 5 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $63.91 | 3 | $0 (2018) |
| Genentech USA, Inc. | $57.90 | 3 | $0 (2018) |
| Daiichi Sankyo Inc. | $57.40 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $53.08 | 3 | $0 (2018) |
| Puma Biotechnology, Inc. | $40.72 | 2 | $0 (2018) |
| Pharmacyclics LLC, An AbbVie Company | $39.25 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $111.61 | 4 | Daiichi Sankyo Inc. ($57.40) |
| 2022 | $96.03 | 1 | Progenics Pharmaceuticals, Inc. ($96.03) |
| 2019 | $108.80 | 6 | EISAI INC. ($41.46) |
| 2018 | $451.93 | 26 | Merck Sharp & Dohme Corporation ($59.70) |
| 2017 | $119.00 | 7 | Pharmacyclics LLC, An AbbVie Company ($39.25) |
All Payment Transactions
44 individual payment records from CMS Open Payments — Page 2 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/19/2018 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Oncology | ||||||
| 08/06/2018 | Eisai Inc. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $22.91 | General |
| Category: Oncology | ||||||
| 07/25/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $18.67 | General |
| Category: Oncology | ||||||
| 07/23/2018 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $17.76 | General |
| Category: Interventional Oncology | ||||||
| 07/13/2018 | Amgen Inc. | Neulasta (Biological), Vectibix | Food and Beverage | In-kind items and services | $13.89 | General |
| Category: Oncology | ||||||
| 06/13/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Oncology | ||||||
| 05/23/2018 | PFIZER INC. | XALKORI (Drug), IBRANCE | Food and Beverage | In-kind items and services | $17.21 | General |
| Category: ONCOLOGY | ||||||
| 05/09/2018 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $18.76 | General |
| Category: Oncology | ||||||
| 05/02/2018 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: ONCOLOGY | ||||||
| 04/20/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Oncology | ||||||
| 04/20/2018 | Seattle Genetics, Inc. | ADCETRIS (Biological) | Education | In-kind items and services | $12.29 | General |
| Category: Oncology | ||||||
| 03/28/2018 | Incyte Corporation | JAKAFI (Drug) | Food and Beverage | Cash or cash equivalent | $16.61 | General |
| Category: Hematology/Oncology | ||||||
| 11/15/2017 | PFIZER INC. | IBRANCE (Drug) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: ONCOLOGY | ||||||
| 09/13/2017 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.83 | General |
| Category: Oncology | ||||||
| 07/21/2017 | Genentech USA, Inc. | GAZYVA (Biological), Rituxan | Food and Beverage | In-kind items and services | $19.27 | General |
| Category: BioOncology | ||||||
| 05/03/2017 | Genentech USA, Inc. | Rituxan (Biological), GAZYVA | Food and Beverage | In-kind items and services | $17.73 | General |
| Category: BioOncology/Immunology | ||||||
| 04/19/2017 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: ONCOLOGY | ||||||
| 02/27/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Oncology | ||||||
| 02/08/2017 | Pharmacyclics LLC, An AbbVie Company | Imbruvica (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Oncology | ||||||
About Dr. Peter Lindenberg, MD
Dr. Peter Lindenberg, MD is a Hematology & Oncology healthcare provider based in Ft Belvoir, Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1629049689.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Peter Lindenberg, MD has received a total of $887.37 in payments from pharmaceutical and medical device companies, with $111.61 received in 2024. These payments were reported across 44 transactions from 21 companies. The most common payment nature is "Food and Beverage" ($875.08).
Ad
Practice Information
- Specialty Hematology & Oncology
- Location Ft Belvoir, VA
- Active Since 01/29/2006
- Last Updated 06/27/2025
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1629049689
Products in Payments
- PYLARIFY (Drug) $96.03
- KEYTRUDA (Biological) $62.38
- Enhertu (Drug) $57.40
- Lenvima (Drug) $41.37
- Nerlynx (Drug) $40.72
- GAZYVA (Biological) $40.17
- Imbruvica (Drug) $39.25
- OPDIVO (Biological) $36.50
- XTANDI (Drug) $35.54
- Halaven (Drug) $34.99
- IMBRUVICA (Drug) $34.95
- ADCETRIS (Biological) $31.19
- EMPLICITI (Biological) $27.41
- ZEJULA (Drug) $23.42
- IBRANCE (Drug) $23.14
- SOMATULINE DEPOT (Drug) $19.30
- TAGRISSO (Drug) $19.29
- Rubraca (Drug) $19.00
- Cabometyx (Drug) $18.76
- NOXAFIL (Drug) $18.17
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.